Analysen zu Novo Nordisk
| 28.08.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.08.24 | Novo Nordisk Neutral | UBS AG | |
| 08.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.24 | Novo Nordisk Underperform | Bernstein Research | |
| 07.08.24 | Novo Nordisk Neutral | UBS AG | |
| 07.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.08.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.08.24 | Novo Nordisk Neutral | UBS AG | |
| 31.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 19.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 12.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 11.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.07.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 02.07.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 28.06.24 | Novo Nordisk Neutral | UBS AG | |
| 27.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.06.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 25.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 24.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 14.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 30.05.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.05.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 15.05.24 | Novo Nordisk Neutral | UBS AG | |
| 14.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 14.05.24 | Novo Nordisk Neutral | UBS AG | |
| 08.05.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.05.24 | Novo Nordisk Overweight | Barclays Capital | |
| 06.05.24 | Novo Nordisk Neutral | UBS AG | |
| 03.05.24 | Novo Nordisk Halten | DZ BANK | |
| 03.05.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.05.24 | Novo Nordisk Overweight | Barclays Capital | |
| 02.05.24 | Novo Nordisk Neutral | UBS AG | |
| 02.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.05.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 13.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.09.23 | Novo Nordisk Overweight | Barclays Capital | |
| 07.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.09.23 | Novo Nordisk Sell | UBS AG | |
| 05.09.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.09.23 | Novo Nordisk Overweight | Barclays Capital |
Aktuelle Aktienanalysen
| 01.05.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | Glencore Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | Inditex Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | Nordex Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | E.ON Hold | Jefferies & Company Inc. | |
| 01.05.25 | Adyen B.V. Parts Sociales Buy | Jefferies & Company Inc. | |
| 01.05.25 | Meta Platforms Buy | Jefferies & Company Inc. | |
| 01.05.25 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.25 | Glencore Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.25 | Microsoft Outperform | RBC Capital Markets | |
| 01.05.25 | Stellantis Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | Adyen B.V. Parts Sociales Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | DHL Group Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | Meta Platforms Outperform | RBC Capital Markets | |
| 01.05.25 | Kering Sector Perform | RBC Capital Markets | |
| 01.05.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 01.05.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 01.05.25 | GSK Neutral | UBS AG | |
| 01.05.25 | TotalEnergies Buy | UBS AG | |
| 01.05.25 | ams-OSRAM Buy | UBS AG | |
| 01.05.25 | Nemetschek Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | Lufthansa Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 01.05.25 | Airbus Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | Meta Platforms Buy | UBS AG | |
| 01.05.25 | Tesla Sell | UBS AG | |
| 01.05.25 | Deutsche Bank Buy | UBS AG | |
| 01.05.25 | Adyen B.V. Parts Sociales Buy | UBS AG | |
| 30.04.25 | Mercedes-Benz Group Outperform | RBC Capital Markets | |
| 30.04.25 | Airbus Hold | Jefferies & Company Inc. | |
| 30.04.25 | Apple Hold | Jefferies & Company Inc. | |
| 30.04.25 | E.ON Outperform | Bernstein Research | |
| 30.04.25 | BBVA Outperform | RBC Capital Markets | |
| 30.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.04.25 | Stellantis Sector Perform | RBC Capital Markets | |
| 30.04.25 | Glencore Buy | Jefferies & Company Inc. | |
| 30.04.25 | JENOPTIK Neutral | UBS AG | |
| 30.04.25 | Airbus Outperform | RBC Capital Markets | |
| 30.04.25 | WACKER CHEMIE Kaufen | DZ BANK | |
| 30.04.25 | adidas Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.25 | Siltronic Halten | DZ BANK | |
| 30.04.25 | Volkswagen Neutral | JP Morgan Chase & Co. | |
| 30.04.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Iberdrola Buy | UBS AG | |
| 30.04.25 | Unilever Kaufen | DZ BANK |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.